AnPac Bio-Medical Science Co Ltd's stock had its IPO on January 30, 2020, making it an older stock than just 0.18% of US equities in our set.
ANPC's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 4.3% of US stocks.
AnPac Bio-Medical Science Co Ltd's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -94.37%, greater than the shareholder yield of only 3.22% of stocks in our set.
Stocks that are quantitatively similar to ANPC, based on their financial statements, market capitalization, and price volatility, are DRIO, DHIL, GRIL, FN, and EMX.
AnPac Bio-Medical Science Co., Ltd. (ANPC) Company Bio
Anpac Bio-Medical Science Co., Ltd., a development-stage biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquartered in Lishui, the People's Republic of China.
SAN JOSE, Calif., Dec. 14, 2020 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, announced today it has made significant progress in detecting pre-cancer diseases. This development was made via novel sensor design, sensor fabrication, detection process, signal collection, signal processing and proprietary algorithms, which has been validated in both multi-year retrospective and prospective, large sample and population studies. The Company recently completed a prospective large population screening of over 110,000 individuals (and over 150,000 samples throughout this study with some individuals tested multiple times ov...
Gainers AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) shares jumped 104% to close at $7.14 on Wednesday after the company issued strong sales forecast for FY20. Newborn Acquisition Corp. (NASDAQ: NBAC ) jumped 86.2% to close at $22.27 after gaining around 8% on Tuesday. Mmtec, Inc. (NASDAQ: MTC ) jumped 67.5% to close at $2.01 on Wednesday after climbing over 11% on Tuesday. Future FinTech Group Inc. (NASDAQ: FTFT ) gained 40.2% to close at $3.00. Slack Technologies, Inc. (NYSE: WORK ) climbed 37.6% to close at $40.70 following reports indicating Salesforce has held M&A talks with the company. Fisker Inc. (NYSE: FSR ) rose 35.3% to close at $21.61 after Citigroup initiated coverage on the stock with a Buy rating and a price target of $26 per share. Appian Corporation (NASDAQ: A...
Gainers AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC) shares climbed 99.7% to $6.99 after the company issued strong sales forecast for FY20. Mmtec, Inc. (NASDAQ: MTC) climbed 82.2% to $2.20 after climbing over 11% on Tuesday. Newborn Acquisition Corp. (NASDAQ: NBAC) climbed 56.4% to $18.70 after gaining around 8% on Tuesday. Cocrystal Pharma,… Read More »50 Stocks Moving In Wednesday’s Mid-Day Session